Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/39083| Título : | Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline |
| Autor : | Beltrán Arroyave, Claudia Patricia Siemieniuk, Reed A C Lytvyn, Lyubov Ming, Jinell Mah Mullen, Rhonda Marama Anam, Florence Otieno, Teresia Guyatt, Gordon H. Taylor, Graham P. Okwen, Patrick Mbah Nduati, Ruth Kinuthia, John Luma, Henry Namme Kirpalani, Haresh Merglen, Arnaud Lesi, Olufunmilayo A. Vandvik, Per Olav Agoritsas, Thomas Bewley, Susan |
| metadata.dc.subject.*: | Fármacos Anti-VIH Anti-HIV Agents Infecciones por VIH HIV Infections Transmisión Vertical de Enfermedad Infecciosa Infectious Disease Transmission, Vertical Complicaciones Infecciosas del Embarazo Pregnancy Complications, Infectious https://id.nlm.nih.gov/mesh/D019380 https://id.nlm.nih.gov/mesh/D015658 https://id.nlm.nih.gov/mesh/D018445 https://id.nlm.nih.gov/mesh/D011251 |
| Fecha de publicación : | 2017 |
| Editorial : | BMJ Publishing Group |
| Citación : | Siemieniuk RAC, Lytvyn L, Mah Ming J, Mullen RM, Anam F, Otieno T, Guyatt GH, Taylor GP, Beltrán-Arroyave C, Okwen PM, Nduati R, Kinuthia J, Luma HN, Kirpalani H, Merglen A, Lesi OA, Vandvik PO, Agoritsas T, Bewley S. Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline. BMJ. 2017 Sep 11;358:j3961. doi: 10.1136/bmj.j3961. |
| Resumen : | ABSTRACT: Approximately 1.4 million women living with HIV become pregnant every year. Most women use antiretroviral therapy, to reduce the risk of vertical transmission or for personal health reasons. Using the GRADE framework according to the BMJ Rapid Recommendation process, we make recommendations for optimal choice of combination antiretroviral regimen considering patient values and preferences, the balance of desirable and undesirable outcomes, their uncertainty, and practical issues. We suggest a zidovudine and lamivudine-based regimen over one that includes tenofovir or emtricitabine (weak recommendation). We recommend alternatives over the combination of tenofovir, emtricitabine, and lopinavir/ritonavir (strong recommendation). |
| metadata.dc.identifier.eissn: | 1756-1833 |
| ISSN : | 0959-8138 |
| metadata.dc.identifier.doi: | 10.1136/bmj.j3961. |
| Aparece en las colecciones: | Artículos de Revista en Ciencias Médicas |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Antiretroviral therapy in pregnant women living with HIV.pdf | Artículo de investigación | 571.9 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons
